Preventive effects of carvedilol on nitrate tolerance - A randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol

被引:27
作者
Watanabe, H
Kakihana, M
Ohtsuka, S
Sugishita, Y
机构
[1] KINU Med Assoc Hosp, Dept Cardiol, Mitsukaido City, Ibaraki 3030016, Japan
[2] Ibaraki Prefectural Univ Hlth Sci, Ami, Ibaraki, Japan
[3] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Div Cardiovasc, Tsukuba, Ibaraki 305, Japan
关键词
D O I
10.1016/S0735-1097(98)00398-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study was designed to compare the preventive effect of nitrate tolerance between carvedilol with antioxidant properties and arotinolol without antioxidant properties. Background. The attenuation of cyclic guanosine monophosphate (cGMP) production due to inactivation of guanylate cyclase by increased superoxide has been reported as a mechanism of nitrate tolerance. Carvedilol has been known to combine alpha- and beta-blockade with antioxidant properties. Methods. To evaluate the preventive effect of nitrate tolerance, 24 patients with untreated hypertension were randomized to receive either carvedilol (10 mg twice a day [carvedilol group, n = 8]), arotinolol (10 mg twice a day [arotinolol group, n = 8]), or placebo (placebo group, n = 8), Vasodilatory response to nitroglycerin (NTG) was assessed with forearm plethysmography by measuring the change in forearm blood flow (FBF) before and 5 min after sublingual administration of 0.3 mg NTG, and at the same time blood samples were taken from veins on the opposite side to measure platelet cGMP, Plethysmography and blood sampling were obtained serially at baseline (day 0), 3 days after carvedilol, arotinolol or placebo administration (day 3) and 3 days after application of a 20 mg/24 h NTG tape concomitantly with carvedilol, arotinolol or placebo (day 6), Results. There was no significant difference in the response of FBF (%FBF) and cGMP (%cGMP) to sublingual administration of NTG on days 0 and 3 among the three groups. On day 6, %FBF and %cGMP were significantly lower in the arotinolol group and the placebo group than days 0 and 3, but these parameters in the carvedilol group were maintained. Conclusions. The results indicated that carvedilol with antioxidant properties may prevent the development of nitrate tolerance during continuous therapy with NTG compared with arotinolol without antioxidant properties, (C) 1998 by the American College of Cardiology.
引用
收藏
页码:1201 / 1206
页数:6
相关论文
共 40 条
[1]   TOLERANCE TO ORGANIC NITRATES [J].
ABRAMS, J .
CIRCULATION, 1986, 74 (06) :1181-1185
[2]   TOLERANCE TOWARDS NITROGLYCERIN, INDUCED INVIVO, IS CORRELATED TO A REDUCED CGMP RESPONSE AND AN ALTERATION IN CGMP TURNOVER [J].
AXELSSON, KL ;
ANDERSSON, RGG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 88 (01) :71-79
[3]   Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state [J].
Bassenge, E ;
Fink, B .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (03) :363-367
[4]   CONTINUOUS ORAL N-ACETYLCYSTEINE TREATMENT AND DEVELOPMENT OF NITRATE TOLERANCE IN PATIENTS WITH STABLE ANGINA-PECTORIS [J].
BOESGAARD, S ;
ALDERSHVILE, J ;
PEDERSEN, F ;
PIETERSEN, A ;
MADSEN, JK ;
GRANDE, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (06) :889-893
[5]   EFFECTS OF NITROVASODILATORS ON PLATELET CYCLIC-NUCLEOTIDE LEVELS IN RABBIT-BLOOD - ROLE FOR CYCLIC-AMP IN SYNERGISTIC INHIBITION OF PLATELET-FUNCTION BY SIN-1 AND PROSTAGLANDIN-E1 [J].
BOWEN, R ;
HASLAM, RJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (03) :424-433
[6]   TOLERANCE TO INTRAVENOUS NITROGLYCERIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - ROLE OF INCREASED INTRAVASCULAR VOLUME, NEUROHUMORAL ACTIVATION AND LACK OF PREVENTION WITH N-ACETYLCYSTEINE [J].
DUPUIS, J ;
LALONDE, G ;
LEMIEUX, R ;
ROULEAU, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (04) :923-931
[7]  
Elkayam U, 1996, CAN J CARDIOL, V12, pC17
[8]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[9]   Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection [J].
Feuerstein, GZ ;
Ruffolo, RR .
EUROPEAN HEART JOURNAL, 1996, 17 :24-29
[10]   SOLVING THE MYSTERY OF NITRATE TOLERANCE - A NEW SCENT ON THE TRAIL [J].
FUNG, HL .
CIRCULATION, 1993, 88 (01) :322-324